CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Dynavax Technologies Corp  (DVAX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

DVAX's Revenue Year on Year Growth by Quarter and Year

Dynavax Technologies's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
DVAX Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 6.27 1.19 2.21 2.93
III Quarter September 2.65 1.55 3.05 3.39
II Quarter June 0.94 0.63 3.50 2.09
I Quarter March 0.69 2.28 2.85 1.81
FY   10.55 5.65 11.61 10.22

Financial Statements
Dynavax Technologies's forth quarter 2016 Revenue $ 6.27 millions DVAX's Income Statement
Dynavax Technologies's forth quarter 2015 Revenue $ 1.19 millions Quarterly DVAX's Income Statement
DVAX's Growth by Division See DVAX's Growth by Segment

DVAX Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December 426.55 % -46.15 % -24.57 % 2.09 %
III Quarter September 70.97 % -49.18 % -10.03 % 26.49 %
II Quarter June 49.21 % -82 % 67.46 % -11.06 %
I Quarter March -69.74 % -20 % 57.46 % -
FY   86.65 % -51.34 % 13.6 % -



DVAX Revenue Growth Comment
Dynavax Technologies Corp achieved in the forth quarter, above Company average Revenue surge of 426.55% year on year, to $ 6.27 millions.

Looking into forth quarter results within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Revenue growth. While Dynavax Technologies Corp' s Revenue doubling of 426.55% ranks overall at the positon no. 55 in the forth quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #13
S&P 500 #55
Revenue Y/Y Growth Statistics
High Average Low
814.74 % 51.74 % -82.08 %
(Dec 31 2016)   (Mar 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DVAX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for DVAX's Competitors
Revenue Growth for Dynavax Technologies's Suppliers
Revenue Growth for DVAX's Customers

You may also want to know
DVAX's Annual Growth Rates DVAX's Profitability Ratios DVAX's Asset Turnover Ratio DVAX's Dividend Growth
DVAX's Roe DVAX's Valuation Ratios DVAX's Financial Strength Ratios DVAX's Dividend Payout Ratio
DVAX's Roa DVAX's Inventory Turnover Ratio DVAX's Growth Rates DVAX's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Exact Sciences Corp  589.15 %$ 589.154 millions
Hci Viocare  554.40 %$ 554.402 millions
Sophiris Bio Inc.  550.00 %$ 550.000 millions
Biosig Technologies, Inc.  507.28 %$ 507.282 millions
Icagen, Inc.  463.97 %$ 463.975 millions
Juno Therapeutics, Inc.  409.47 %$ 409.465 millions
Gtx Corp  374.22 %$ 374.216 millions
Eagle Pharmaceuticals, Inc.  346.31 %$ 346.315 millions
Nuo Therapeutics, Inc.  336.84 %$ 336.844 millions
Sarepta Therapeutics, Inc.  332.64 %$ 332.642 millions
Positiveid Corp  280.62 %$ 280.620 millions
Acelrx Pharmaceuticals Inc  271.97 %$ 271.965 millions
Agios Pharmaceuticals Inc  264.23 %$ 264.233 millions
Aradigm Corp  257.14 %$ 257.143 millions
Organovo Holdings, Inc.  250.91 %$ 250.915 millions
Cord Blood America, Inc.  250.14 %$ 250.144 millions
Neuralstem, Inc.  249.84 %$ 249.840 millions
Cytokinetics Inc  239.62 %$ 239.623 millions
Viveve Medical, Inc.  226.06 %$ 226.064 millions
Intra-cellular Therapies, Inc.  219.30 %$ 219.303 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
CIGF7's Profile
Stock Price
CIGF7's Financials
CIGF7's Expectations
Business Description
Fundamentals
Charts & Quotes
CIGF7's News
Suppliers
CIGF7's Competitors
Customers & Markets
Economic Indicators
CIGF7's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com